Phosphoinositide-3-kinase/akt - Dependent signaling is required for maintenance of [Ca2+]i,ICa, and Ca2+ transients in HL-1 cardiomyocytes

Journal of Biomedical Science

Volumn 19, Issue 1, 2012, Pages

  Graves, Bridget M ^a   Simerly, Thomas ^a   Li, Chuanfu ^a   Williams, David L ^a   Wondergem, Robert ^a  

^a East Tennessee State University   (United States)

Author keywords

Calcium; Electrophysiology; Fura 2; HL 1 cardiomyocytes; Phosphoinositide 3 kinase Akt; Whole cell voltage clamp

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; 5 [5 (4 FLUORO 2 HYDROXYPHENYL)FURFURYLIDENE] 2,4 THIAZOLIDINEDIONE; 9 (1 ANILINOETHYL) 7 METHYL 2 MORPHOLINOPYRIDO[1,2 A]PYRIMIDIN 4 ONE; CALCIUM ION; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; TRICIRIBINE; UNCLASSIFIED DRUG; 2,4 THIAZOLIDINEDIONE DERIVATIVE; 5 (5 (4 FLUORO 2 HYDROXYPHENYL)FURAN 2 YLMETHYLENE)THIAZOLIDINE 2,4 DIONE; 5-(5-(4-FLUORO-2-HYDROXYPHENYL)FURAN-2-YLMETHYLENE)THIAZOLIDINE-2,4-DIONE; CALCIUM; FURA 2; MORPHOLINE DERIVATIVE; PROTEIN KINASE B; PYRIMIDINONE DERIVATIVE;

ANIMAL CELL; ARTICLE; CALCIUM CURRENT; CELL FUNCTION; DOWNSTREAM PROCESSING; DRUG EFFECT; ENZYME ACTIVITY; EXCITATION CONTRACTION COUPLING; HEART MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; ANIMAL; DRUG ANTAGONISM; ELECTROPHYSIOLOGY; GENETICS; HEART CONTRACTION; HEART MUSCLE; METABOLISM; MOUSE; PATCH CLAMP; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY;

MURINAE;

ANIMALS; CALCIUM; ELECTROPHYSIOLOGY; EXCITATION CONTRACTION COUPLING; FURA-2; MICE; MORPHOLINES; MYOCARDIAL CONTRACTION; MYOCARDIUM; MYOCYTES, CARDIAC; PATCH-CLAMP TECHNIQUES; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; PYRIMIDINONES; SIGNAL TRANSDUCTION; THIAZOLIDINEDIONES;

EID: 84862315061     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/1423-0127-19-59     Document Type: Article

References (33)

1. The phosphoinositide 3-kinase pathway. Cantley LC, Cantley LC, Science (New York, NY 2002 296 1655 1657 10.1126/science.296.5573.1655 (Pubitemid 34579158)
2. Phosphoinositide 3-kinase in immunological systems. Fruman DA, Cantley LC, Semin Immunol 2002 14 7 18 10.1006/smim.2001.0337 11884226 (Pubitemid 34250704)
3. Modulation of the phosphoinositide 3-kinase pathway alters innate resistance to polymicrobial sepsis. Williams DL, Li C, Ha T, Ozment-Skelton T, Kalbfleisch JH, Preiszner J, Brooks L, Breuel K, Schweitzer JB, J Immunol 2004 172 449 456 14688354 (Pubitemid 38020500)
4. Akt decreases lymphocyte apoptosis and improves survival in sepsis. Bommhardt U, Chang KC, Swanson PE, Wagner TH, Tinsley KW, Karl IE, Hotchkiss RS, J Immunol 2004 172 7583 7591 15187138 (Pubitemid 38747622)
5. Glucan phosphate attenuates cardiac dysfunction and inhibits cardiac MIF expression and apoptosis in septic mice. Ha T, Hua F, Grant D, Xia Y, Ma J, Gao X, Kelley J, Williams DL, Kalbfleisch J, Browder IW, et al. Am J Physiol 2006 291 1910 H1918
6. Temporally controlled overexpression of cardiac-specific PI3Kalpha induces enhanced myocardial contractility-a new transgenic model. Yano N, Tseng A, Zhao TC, Robbins J, Padbury JF, Tseng YT, Am J Physiol Heart Circ Physiol 2008 295 1690 H1694 10.1152/ajpheart.00531.2008 18723766
7. Loss of cardiac phosphoinositide 3-kinase p110 alpha results in contractile dysfunction. Lu Z, Jiang YP, Wang W, Xu XH, Mathias RT, Entcheva E, Ballou LM, Cohen IS, Lin RZ, Circulation 2009 120 318 325 10.1161/ CIRCULATIONAHA.109.873380 19597047
8. HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte. Claycomb WC, Lanson NA, Stallworth BS, Egeland DB, Delcarpio JB, Bahinski A, Izzo NJ, Proc Natl Acad Sci USA 1998 95 2979 2984 10.1073/pnas.95.6.2979 9501201 (Pubitemid 28135840)
9. Cardiac physiology at the cellular level: use of cultured HL-1 cardiomyocytes for studies of cardiac muscle cell structure and function. White SM, Constantin PE, Claycomb WC, Am J Physiol Heart Circ Physiol 2004 286 823 H829 14766671
10. Functional expression of L- and T-type Ca2+ channels in murine HL-1 cells. Xia M, Salata JJ, Figueroa DJ, Lawlor AM, Liang HA, Liu Y, Connolly TM, J Mol Cell Cardiol 2004 36 111 119 10.1016/j.yjmcc.2003.10.007 14734053 (Pubitemid 38084796)
11. Interleukin-18 is a pro-hypertrophic cytokine that acts through a phosphatidylinositol 3-kinase-phosphoinositide-dependent kinase-1-Akt-GATA4 signaling pathway in cardiomyocytes. Chandrasekar B, Mummidi S, Claycomb WC, Mestril R, Nemer M, J Biol Chem 2005 280 4553 4567 15574430 (Pubitemid 40288623)
12. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ, Pflugers Arch 1981 391 85 100 10.1007/BF00656997 6270629 (Pubitemid 11012976)
13. Functional expression of the hyperpolarization-activated, non-selective cation current I(f) in immortalized HL-1 cardiomyocytes. Sartiani L, Bochet P, Cerbai E, Mugelli A, Fischmeister R, J Physiol 2002 545 81 92 10.1113/jphysiol.2002.021535 12433951 (Pubitemid 35386129)
14. Lipopolysaccharides directly decrease Ca2+ oscillations and the hyperpolarization-activated nonselective cation current If in immortalized HL-1 cardiomyocytes. Wondergem R, Graves BM, Ozment-Skelton TR, Li C, Williams DL, Am J Physiol Cell Physiol 2010 299 665 C671 10.1152/ajpcell.00129.2010 20573997
15. Exploring the specificity of the PI3K family inhibitor LY294002. Gharbi SI, Zvelebil MJ, Shuttleworth SJ, Hancox T, Saghir N, Timms JF, Waterfield MD, Biochem J 2007 404 15 21 10.1042/BJ20061489 17302559 (Pubitemid 46788080)
16. Akt is a major downstream target of PI3-kinase involved in angiotensin II-induced proliferation. Dugourd C, Gervais M, Corvol P, Monnot C, Hypertension 2003 41 882 890 10.1161/01.HYP.0000060821.62417.35 12623864 (Pubitemid 36418461)
17. Akt regulates L-type Ca2+ channel activity by modulating Cavalpha1 protein stability. Catalucci D, Zhang DH, DeSantiago J, Aimond F, Barbara G, Chemin J, Bonci D, Picht E, Rusconi F, Dalton ND, et al. J Cell Biol 2009 184 923 933 10.1083/jcb.200805063 19307602
18. Ca channels in cardiac myocytes: structure and function in Ca influx and intracellular Ca release. Bers DM, Perez-Reyes E, Cardiovasc Res 1999 42 339 360 10.1016/S0008-6363(99)00038-3 10533572 (Pubitemid 29243162)
19. Ca2+ signalling between single L-type Ca2+ channels and ryanodine receptors in heart cells. Wang SQ, Song LS, Lakatta EG, Cheng H, Nature 2001 410 592 596 10.1038/35069083 11279498 (Pubitemid 32267204)
20. Cardiac excitation-contraction coupling. Bers DM, Nature 2002 415 198 205 10.1038/415198a 11805843 (Pubitemid 34059525)
21. Reduced L-type calcium current in ventricular myocytes from endotoxemic guinea pigs. Zhong J, Hwang TC, Adams HR, Rubin LJ, Am J Physiol 1997 273 2312 H2324 9374768
22. Reduced L-type calcium current in ventricular myocytes from pigs with hyperdynamic septic shock. Stengl M, Bartak F, Sykora R, Chvojka J, Benes J, Krouzecky A, Novak I, Sviglerova J, Kuncova J, Matejovic M, Crit Care Med 2010 38 579 587 10.1097/CCM.0b013e3181cb0f61 20029342
23. Mechanism of enhanced cardiac function in mice with hypertrophy induced by overexpressed Akt. Kim YK, Kim SJ, Yatani A, Huang Y, Castelli G, Vatner DE, Liu J, Zhang Q, Diaz G, Zieba R, et al. J Biol Chem 2003 278 47622 47628 10.1074/jbc.M305909200 13129932 (Pubitemid 37523206)
24. lipopolysaccharide induces atrial arrhythmogenesis via down-regulation of L-type Ca2+ channel genes in rats. Okazaki R, Iwasaki YK, Miyauchi Y, Hirayama Y, Kobayashi Y, Katoh T, Mizuno K, Sekiguchi A, Yamashita T, Int Hear J 2009 50 353 363 10.1536/ihj.50.353
25. Endotoxin impairs the human pacemaker current If. Zorn-Pauly K, Pelzmann B, Lang P, Machler H, Schmidt H, Ebelt H, Werdan K, Koidl B, Muller-Werdan U, Shock (Augusta, Ga 2007 28 655 661 (Pubitemid 350135469)
26. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Murry CE, Jennings RB, Reimer KA, Circulation 1986 74 1124 1136 10.1161/01.CIR.74.5.1124 3769170 (Pubitemid 17174962)
27. Endotoxin pretreatment increases endogenous myocardial catalase activity and decreases ischemia-reperfusion injury of isolated rat hearts. Brown JM, Grosso MA, Terada LS, Whitman GJ, Banerjee A, White CW, Harken AH, Repine JE, Proc Natl Acad Sci U S A 1989 86 2516 2520 10.1073/pnas.86.7.2516 2648406 (Pubitemid 19102539)
28. PI3K and negative regulation of TLR signaling. Fukao T, Koyasu S, Trends Immunol 2003 24 358 363 10.1016/S1471-4906(03)00139-X 12860525 (Pubitemid 36830961)
29. The phosphatidylinositol 3-kinase-Akt pathway limits lipopolysaccharide activation of signaling pathways and expression of inflammatory mediators in human monocytic cells. Guha M, Mackman N, J Biol Chem 2002 277 32124 32132 10.1074/jbc.M203298200 12052830 (Pubitemid 34969025)
30. TLR2 ligands induce cardioprotection against ischaemia/reperfusion injury through a PI3K/Akt-dependent mechanism. Ha T, Hu Y, Liu L, Lu C, McMullen JR, Kelley J, Kao RL, Williams DL, Gao X, Li C, Cardiovasc Res 2010 87 694 703 10.1093/cvr/cvq116 20421349
31. Modulating Toll-like receptor mediated signaling by (1-3)-beta-D-glucan rapidly induces cardioprotection. Li C, Ha T, Kelley J, Gao X, Qiu Y, Kao RL, Browder W, Williams DL, Cardiovasc Res 2004 61 538 547 10.1016/j.cardiores.2003. 09.007 14962484 (Pubitemid 38210159)
32. Attenuation of cardiac dysfunction by HSPA12B in endotoxin-induced sepsis in mice through a PI3K-dependent mechanism. Zhou H, Qian J, Li C, Li J, Zhang X, Ding Z, Gao X, Han Z, Cheng Y, Liu L, Cardiovasc Res 2011 89 109 118 10.1093/cvr/cvq268 20733008
33. Characterization of the rapidly activating delayed rectifier potassium current, I (Kr), in HL-1 mouse atrial myocytes. Toyoda F, Ding WG, Zankov DP, Omatsu-Kanbe M, Isono T, Horie M, Matsuura H, J Membr Biol 2010 235 73 87 10.1007/s00232-010-9257-2 20490473